Company intelligence / Profile preview

AEMS Corp

Livermore, California, United Statesaems.org ↗

Ownership: Private
Development stage: Other

Overview

AEMS Corp specializes in solving complex formulation challenges—especially viscosity issues—for high-concentration biologic injectables, siRNA therapeutics, small molecules, antimicrobial coatings, food preservatives. Their proprietary automated facility enables high-throughput microscale experiments to optimize formulations efficiently. They have developed novel systems such as the Agent Delivery Matrix for safe pathogen protection in food applications. No direct clinical trial results are reported as they primarily provide technology/services to other companies.

Modalities: Small moleculesiRNA therapeuticsBiologic
Industry: Drug Discovery Services

Partnerships

Collaborates with world-renowned experts in biotechnology; actively seeking additional partners but no specific partner names disclosed publicly.

Beyond the preview

Go deeper on AEMS Corp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AEMS Corp.

Explore the full profile